CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-02 | Kummeth Charles R. Chief Executive Officer | Shares withheld for taxes | −42,005 | $510.78 | $21.5M | 196,601 |
| 2021-09-02 | Kummeth Charles R. Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −73,492 | 100,450 | ||
| 2021-09-02 | Hippel James Chief Financial Officer | Option exercise | +10,000 | $106.59 | $1.1M | 20,855 |
| 2021-09-02 | Hippel James Chief Financial Officer | Sale | −9,993 | $507.22 | $5.1M | 10,862 |
| 2021-09-02 | Hippel James Chief Financial Officer | Sale | −7 | $509.17 | $4K | 10,855 |
| 2021-09-02 | Hippel James Chief Financial Officer | Option exercise · Stock Options (Right to Buy) | −10,000 | 0 | ||
| 2021-09-02 | Furlow Brenda S. SVP - General Counsel | Option exercise | +6,871 | $125.05 | $859K | 14,491 |
| 2021-09-02 | Furlow Brenda S. SVP - General Counsel | Sale | −5,295 | $509.67 | $2.7M | 9,196 |
| 2021-09-02 | Furlow Brenda S. SVP - General Counsel | Sale | −1,576 | $510.82 | $805K | 7,620 |
| 2021-09-02 | Furlow Brenda S. SVP - General Counsel | Option exercise · Stock Options (Right to Buy) | −6,871 | 9,503 | ||
| 2021-08-31 | Eansor Norman David President-Protein Sciences | Sale | −1,538 | $503.07 | $774K | 1,318 |
| 2021-08-31 | Furlow Brenda S. SVP - General Counsel | Option exercise | +5,000 | $125.05 | $625K | 12,620 |
| 2021-08-31 | Furlow Brenda S. SVP - General Counsel | Sale | −323 | $503.24 | $163K | 12,297 |
| 2021-08-31 | Furlow Brenda S. SVP - General Counsel | Sale | −1,569 | $505.26 | $793K | 10,728 |
| 2021-08-31 | Furlow Brenda S. SVP - General Counsel | Sale | −3,108 | $506.12 | $1.6M | 7,620 |
| 2021-08-31 | Furlow Brenda S. SVP - General Counsel | Option exercise · Stock Options (Right to Buy) | −5,000 | 16,374 | ||
| 2021-08-23 | Nusse Roeland Director | Option exercise | +4,000 | $70.35 | $281K | 10,765 |
| 2021-08-23 | Nusse Roeland Director | Sale | −4,000 | $481.52 | $1.9M | 6,765 |
| 2021-08-23 | Nusse Roeland Director | Option exercise · Stock Option (right to buy) | −4,000 | 0 | ||
| 2021-08-23 | BAUMGARTNER ROBERT V Director | Option exercise | +4,000 | $87.39 | $350K | 13,612 |
Page 29 of 32 · 626 trades